Clevergene signs MoU with Rajiv Gandhi Centre for Biotechnology
The MoU has been signed to establish a state-of-the-art genomics centre at Thiruvananthapuram
Clevergene Biocorp yesterday signed a Memorandum of Understanding (MoU) with the Rajiv Gandhi Centre for Biotechnology (RGCB) to establish a state-of-the-art genomics centre at Thiruvananthapuram, Clevergene said in a statement.
In a first of its kind in Kerala, the state-of-the-art genomics centre will house the latest DNA sequencing equipment like the Illumina NovaSeq and other allied infrastructure to support cutting-edge research in plant biotechnology, infections, cancer and other chronic diseases, said the statement.
It further mentioned that the services of this high-throughput genomics centre will be open for use in research to other institutes and industry, and will provide services like gene expression analysis, epigenetics and genome analysis including that of COVID-19 virus.
The MoU was represented by Professor Chandrabhas Narayana, Director, RGBC; S Mohanan Nair, Chief Controller, RGBC; Dr TR Santhosh Kumar and Tony Jose, CEO, Clevergene Biotech and Shiv Mohan Singh Chief Commercial Officer, Clevergene Biotech.